Advertisement for orthosearch.org.uk
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

General Orthopaedics

FIRST GENERATION ONCE ANNEALED HIGHLY CROSS-LINKED POLYETHYLENE EXHIBITS LOW WEAR AT 12 YEARS

The International Society for Technology in Arthroplasty (ISTA), 27th Annual Congress. PART 4.



Abstract

Background

A first generation once annealed highly crosslinked polyethylene (HXLPE) was introduced in 1998. At 8 years it was reported to have a 78% reduction in wear compared with conventional polyethylene and no osteolysis. However, concerns regarding the long-term performance and oxidative resistance of this annealed material exist because of the presence of free radicals.

Questions/purposes

We therefore addressed the following questions: (1) Does the improvement in wear observed at earlier follow-up continue out to 15 years? (2) What is the incidence of osteolysis in this group of patients?

Methods

We retrospectively reviewed 48 prospectively followed patients who had 50 hips with a once annealed HXLPE and were followed an average of 12 years (15 years maximum). Linear head penetration and cup position were measured from AP radiographs at early, 1-year, 5-year, and most recent follow-ups. There were 26 females, 22 males, with an average age of 61 years.

Results

At average 12 years follow-up, annual linear wear was 0.018 mm (SD = 0.024). Average cup inclination was 50.2 degrees (SD = 5.1 range 48 to 64) and anteversion was 18.6 (SD = 8.3, range 3 to 35). No mechanical failure or osteolysis has been found on routine x-rays to date.

Conclusions

At 8 year follow this once annealed material had a reported linear wear rate of 0.031mm /year. We now report, at a 12 years average 15 years maximum follow-up, a further reduction in linear wear of 0.018mm/yr. and no mechanical failures or osteolysis (Figure-1).


Email: